Skip to main content
WoMWeb of Medicine
SearchGraphHistory
Family Medicine›Condition·Updated Jul 11, 2026·v1

Adult Preventive Health Maintenance

Adult preventive health maintenance involves systematic delivery of evidence-based screenings, immunizations, and counseling. Key interventions include colorectal, breast, and cervical cancer screening; cardiovascular risk assessment with statin and aspirin use; vaccinations (influenza, pneumococcal, zoster, Tdap); and lifestyle counseling. Tailor to individual risk factors and age.

High Evidence0 references·422 words·2 min read·v1
preventive medicineadult health maintenancescreeningcounselingimmunizationUSPSTF

Quick Reference

RxDrug of choiceAspirin 81 mg daily for primary prevention in select adults aged 40-59 with ASCVD risk ≥10% and no bleeding risk.
AltAlternativesStatins (atorvastatin, rosuvastatin) for primary prevention; nicotine replacement therapy or varenicline for smoking cessation.
⊘AvoidAspirin for primary prevention in adults ≥60 years; routine screening tests without evidence (e.g., ovarian cancer screening).
DxTest of choiceColonoscopy for colorectal cancer screening; mammography for breast cancer; Pap smear for cervical cancer.
ScKey scoreASCVD risk calculator (10-year risk) for statin and aspirin decisions; PHQ-9 for depression screening.
→When to referAbnormal screening results (e.g., positive FIT, abnormal mammogram, high-risk HPV); complex risk factor management; substance use disorders.
Tailor preventive care to age, sex, and risk factors using USPSTF grade A and B recommendations. Screen for colorectal, breast, cervical cancers, hypertension, diabetes, and dyslipidemia. Vaccinate according to schedule. Counsel on tobacco, alcohol, diet, and exercise.
Adult preventive health maintenance encompasses a broad range of screenings, counseling, and immunizations aimed at reducing morbidity and mortality. This summary condenses the available evidence-based recommendations, though the detailed page currently lacks specific articles for many core sections. The pearls highlight the importance of each domain.

Overview and Recommendations

Background

  • •Adult preventive health maintenance encompasses a set of evidence-based interventions aimed at preventing disease, detecting conditions early, and promoting healthy behaviors in asymptomatic adults. It is the cornerstone of primary care, with the U.S. Preventive Services Task Force (USPSTF) providing grade A and B recommendations that form the basis of clinical practice.
  • •The approach is stratified by age, sex, and risk factors. For example, colorectal cancer screening begins at age 45 for average-risk adults, while breast cancer screening with mammography is recommended biennially starting at age 40. Cervical cancer screening with Pap smear starts at age 21.
  • •Immunizations are a critical component: annual influenza vaccine for all adults, Tdap once in adulthood, pneumococcal vaccines (PCV15/PCV20) at age 65 or earlier for high-risk, and the recombinant zoster vaccine (RZV) at age 50.
  • •Cardiovascular risk assessment using the guides statin therapy and aspirin use. The USPSTF recommends low-dose aspirin (81 mg daily) for primary prevention of CVD in adults aged 40-59 with a 10-year ASCVD risk ≥10% and no increased bleeding risk.
  • •Tobacco cessation counseling and pharmacotherapy (e.g., nicotine replacement, varenicline) are among the most cost-effective interventions. The USPSTF recommends that clinicians ask all adults about tobacco use and provide behavioral interventions and FDA-approved pharmacotherapy.
  • •Screening for depression, unhealthy alcohol use, and intimate partner violence is recommended in appropriate populations. The PHQ-9 and AUDIT-C are validated tools.

Evaluation

  • •Suspect the need for preventive health maintenance at every well-visit or new patient encounter. Ask about age, sex, race/ethnicity, family history, personal medical history, and lifestyle factors (smoking, alcohol, diet, physical activity).
  • •Examine vital signs: blood pressure, BMI, waist circumference. Measure BP accurately with proper technique; elevated BP (≥130/80) requires confirmation and risk assessment.
  • •Order age- and sex-appropriate screenings: For women aged 40-74, mammography every 2 years; for women aged 21-65, Pap smear every 3 years (or co-testing with HPV every 5 years starting at age 30). For men and women aged 45-75, colorectal cancer screening (colonoscopy every 10 years, FIT annually, or other options).
  • •Assess cardiovascular risk using the for adults aged 40-79 without known CVD. This guides statin and aspirin recommendations.
  • •Screen for diabetes: fasting glucose or HbA1c in adults aged 40-70 who are overweight or obese, or earlier if risk factors.
  • •Screen for lipid disorders: fasting lipid panel in men aged 35+ and women aged 45+ with risk factors, or earlier if family history.
  • •Screen for osteoporosis: DXA scan in women aged 65+ and men aged 70+, or earlier if risk factors.
  • •Screen for hepatitis C: one-time for adults aged 18-79; for HIV: at least once for adults aged 15-65.
  • •Assess immunization status: review vaccination records for influenza, Tdap, pneumococcal, zoster, and COVID-19. Offer vaccines as indicated.
  • •Also consider: screening for depression (PHQ-9), anxiety (GAD-7), unhealthy alcohol use (AUDIT-C), and tobacco use. Provide counseling and referral as needed.
  • •Diagnostic criteria for hypertension: BP ≥130/80 on two separate occasions. For diabetes: HbA1c ≥6.5% or fasting glucose ≥126 mg/dL. For hyperlipidemia: LDL-C thresholds vary by risk.
  • •Also consider: genetic testing for hereditary cancer syndromes if strong family history (e.g., BRCA for breast/ovarian cancer, Lynch syndrome for colorectal cancer).

Management

  • •Initiate statin therapy for primary prevention in adults aged 40-75 with one or more CVD risk factors and a 10-year ASCVD risk ≥7.5%: atorvastatin 10-20 mg daily or rosuvastatin 5-10 mg daily. Monitor lipid panel at 4-12 weeks, then annually.
  • •For adults aged 40-59 with ASCVD risk ≥10% and no increased bleeding risk, consider low-dose aspirin 81 mg daily for primary prevention. Do not routinely use aspirin for primary prevention in adults aged ≥60 due to bleeding risk.
  • •Screen for colorectal cancer starting at age 45: colonoscopy every 10 years (preferred), or FIT annually. If positive FIT, refer for colonoscopy.
  • •For breast cancer screening: mammography every 2 years for women aged 40-74. For women aged 75+ or with limited life expectancy, individualize.
  • •For cervical cancer screening: Pap smear every 3 years ages 21-29; Pap + HPV co-testing every 5 years ages 30-65. Discontinue after age 65 if adequate prior screening.
  • •Administer influenza vaccine annually: standard dose or high-dose for ≥65. Administer Tdap once in adulthood, then Td booster every 10 years.
  • •Administer pneumococcal vaccine: PCV15 or PCV20 at age 65 (or earlier if high-risk). If PCV15 given, follow with PPSV23 after.
  • •Administer recombinant zoster vaccine (RZV) two doses 2-6 months apart starting at age 50, even if prior shingles or Zostavax.
  • •For tobacco cessation: Ask, Advise, Assess, Assist, Arrange. Offer nicotine replacement therapy (patch, gum, lozenge) or varenicline 0.5 mg daily increasing to 1 mg BID. Refer to quitline.
  • •For unhealthy alcohol use: brief intervention using AUDIT-C. For moderate to severe alcohol use disorder, consider pharmacotherapy (naltrexone 50 mg daily, acamprosate 666 mg TID) and refer to specialist.
  • •For obesity (BMI ≥30): offer intensive behavioral interventions (≥12 sessions per year) and consider pharmacotherapy (orlistat 120 mg TID, liraglutide 3 mg daily, semaglutide 2.4 mg weekly) or bariatric surgery referral if BMI ≥35 with comorbidities.
  • •Monitor blood pressure annually; if elevated, confirm with ambulatory monitoring. Initiate antihypertensive therapy if BP ≥140/90 (or ≥130/80 with CVD risk). First-line: thiazide diuretic, ACEi, ARB, or CCB.
  • •Screen for depression with PHQ-9; if positive (score ≥10), assess severity and suicide risk. Offer antidepressant therapy (SSRI first-line: sertraline 50 mg daily, fluoxetine 20 mg daily) or refer to cognitive behavioral therapy.
  • •What NOT to do: Do not screen for ovarian cancer with CA-125 or transvaginal ultrasound in average-risk women. Do not screen for testicular cancer with self-exam. Do not routinely screen for thyroid cancer with ultrasound. Do not use aspirin for primary prevention in adults ≥60.
  • •When to refer: to cardiology if complex dyslipidemia or hypertension refractory to therapy; to gastroenterology for abnormal colonoscopy findings; to oncology for abnormal mammogram or Pap; to endocrinology for diabetes management; to smoking cessation specialist if pharmacotherapy fails.
  • •Discharge criteria (for well-visit): ensure all age-appropriate screenings are ordered or scheduled, immunizations are updated, and counseling is documented. Provide patient with a preventive care summary.

Board Review — High Yield

  • •Colorectal cancer screening start age 45, USPSTF grade A recommendation for adults aged 45-75; colonoscopy every 10 years or FIT annually.
  • •Mammography biennial starting age 40, Grade B for women 40-74; grade C for 75+.
  • •Cervical cancer screening, Pap alone every 3 years (21-29), co-testing every 5 years (30-65). Stop at 65 if adequate prior screening.
  • •Aspirin for primary prevention, Grade B for adults 40-59 with 10-year ASCVD risk ≥10% and no bleeding risk; grade D for ≥60.
  • •Statin for primary prevention, Grade B for adults 40-75 with ≥1 CVD risk factor and 10-year risk ≥7.5%.
  • •Pneumococcal vaccine, PCV15 or PCV20 at 65; if PCV15, follow with PPSV23 after.
  • •Shingles vaccine, RZV two doses starting at age 50, even if prior shingles.
  • •Tobacco cessation, Ask every visit; offer behavioral support and pharmacotherapy (varenicline or NRT).
  • •Depression screening, PHQ-9; treat with SSRI or refer for CBT.
  • •Obesity screening, BMI ≥30; offer intensive behavioral interventions and consider pharmacotherapy or surgery.

Deep Dive — Evidence Details

References

    Revision History

    All updates applied to this page

    Loading revisions…